Chemical formula: C₁₉H₂₄N₂O Molecular mass: 296.414 g/mol PubChem compound: 6337614
Palonosetron is a selective high-affinity receptor antagonist of the 5HT3 receptor.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| A04AA05 | Palonosetron | A Alimentary tract and metabolism → A04 Antiemetics and antinauseants → A04A Antiemetics and antinauseants → A04AA Serotonin (5HT3) antagonists |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| ALOXI Soft capsule | European Medicines Agency (EU) | MPI, EU: SmPC | |
| ALOXI Solution for injection | European Medicines Agency (EU) | MPI, EU: SmPC |
Palonosetron is an active ingredient of these brands:
United States (US)Australia (AU)Austria (AT)Brazil (BR)Croatia (HR)Cyprus (CY)
Ecuador (EC)Estonia (EE)Finland (FI)Hong Kong (HK)Ireland (IE)Israel (IL)Japan (JP)
Lithuania (LT)Malta (MT)
Mexico (MX)
Netherlands (NL)New Zealand (NZ)Romania (RO)Singapore (SG)South Africa (ZA)Spain (ES)Tunisia (TN)
Turkey (TR)
United Kingdom (UK)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
